PAA 4.88% 19.5¢ pharmaust limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-330

  1. 1,391 Posts.
    lightbulb Created with Sketch. 291
    I think so. There's about $15 million in option money coming so maybe raise another $20 million. The trial has to funded. I'd rather do a CR than do a cheap partnership deal. They should be able to raise at no discount like last time.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.